{"version":"1.0","provider_name":"Canadian Drug Policy Coalition","provider_url":"https:\/\/drugpolicy.ca\/fr\/","author_name":"Canadian Drug Policy Coalition","author_url":"https:\/\/drugpolicy.ca\/fr\/author\/canadian-drug-policy-coalition\/","title":"CDSA Exemption and Interpretive Guide for Controlled Substances - Canadian Drug Policy Coalition","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"Ujs40xkOf6\"><a href=\"https:\/\/drugpolicy.ca\/fr\/cdsa-exemption-and-interpretive-guide-for-controlled-substances\/\">CDSA Exemption and Interpretive Guide for Controlled Substances<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/drugpolicy.ca\/fr\/cdsa-exemption-and-interpretive-guide-for-controlled-substances\/embed\/#?secret=Ujs40xkOf6\" width=\"600\" height=\"338\" title=\"&#8220;CDSA Exemption and Interpretive Guide for Controlled Substances&#8221; &#8212; Canadian Drug Policy Coalition\" data-secret=\"Ujs40xkOf6\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/drugpolicy.ca\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","thumbnail_url":"https:\/\/www.drugpolicy.ca\/wp-content\/uploads\/2020\/03\/Capture-2.jpg","thumbnail_width":1973,"thumbnail_height":1242,"description":"\"We strongly encourage all partners to work to implement these exemptions in their jurisdictionsand welcome any additional suggestions you may have to maintain Canadians\u2019 access tocontrolled substances for medical reasons during the pandemic.\""}